Stockscreener 앱 받기
341.78
1.14%
3.84
시간 외 거래:
341.78
전일 마감가:
$337.94
열려 있는:
$337.75
하루 거래량:
472.87K
Relative Volume:
0.70
시가총액:
$24.06B
수익:
$2.36B
순이익/손실:
$236.10M
주가수익비율:
103.88
EPS:
3.29
순현금흐름:
$382.50M
1주 성능:
-1.91%
1개월 성능:
+10.38%
6개월 성능:
+37.60%
1년 성능:
+48.31%
1일 변동 폭
$336.00
$351.94
1주일 범위
$330.00
$353.50
52주 변동 폭
$225.37
$353.50
인슐렛 코퍼레이션 Stock (PODD) Company Profile
명칭
Insulet Corporation
전화
978-600-7000
주소
100 NAGOG PARK, ACTON, MA
PODD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
341.78 | 23.77B | 2.36B | 236.10M | 382.50M | 3.29 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
인슐렛 코퍼레이션 Stock (PODD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-08 | 재개 | Oppenheimer | Outperform |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-05-13 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | 개시 | RBC Capital Mkts | Outperform |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-07 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-08-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-01 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-07-28 | 개시 | Wells Fargo | Overweight |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 개시 | BofA/Merrill | Neutral |
| 2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-12-10 | 개시 | CFRA | Sell |
| 2019-10-23 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-10-04 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-10-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-08-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-06-10 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-04-20 | 개시 | Berenberg | Buy |
| 2018-02-22 | 재확인 | Barclays | Overweight |
| 2018-01-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 개시 | Barclays | Overweight |
모두보기
인슐렛 코퍼레이션 주식(PODD)의 최신 뉴스
Fred Alger Management LLC Lowers Stock Position in Insulet Corporation $PODD - MarketBeat
Meiji Yasuda Asset Management Co Ltd. Reduces Stock Holdings in Insulet Corporation $PODD - MarketBeat
MBB Public Markets I LLC Makes New Investment in Insulet Corporation $PODD - MarketBeat
Laetitia Cousin Sells 797 Shares of Insulet (NASDAQ:PODD) Stock - MarketBeat
AQR Capital Management LLC Has $21.79 Million Holdings in Insulet Corporation $PODD - MarketBeat
Alliancebernstein L.P. Raises Holdings in Insulet Corporation $PODD - MarketBeat
Insulet (NASDAQ:PODD) SVP Prem Singh Sells 687 Shares - MarketBeat
Vancity Investment Management Ltd Buys Shares of 2,244 Insulet Corporation $PODD - MarketBeat
Insulet (NASDAQ:PODD) Reaches New 12-Month High After Analyst Upgrade - MarketBeat
Oppenheimer Forecasts Strong Price Appreciation for Insulet (NASDAQ:PODD) Stock - MarketBeat
822 Shares in Insulet Corporation $PODD Purchased by Vident Advisory LLC - MarketBeat
Insulet (NASDAQ:PODD) Stock Price Down 5% After Insider Selling - MarketBeat
Why Insulet (PODD) is a Top Growth Stock for the Long-Term - Yahoo Finance
Geneos Wealth Management Inc. Increases Holdings in Insulet Corporation $PODD - MarketBeat
JPMorgan Adjusts Price Target on Insulet to $415 From $340, Maintains Overweight Rating - MarketScreener
Jacobs Levy Equity Management Inc. Makes New $24.48 Million Investment in Insulet Corporation $PODD - MarketBeat
Parkman Healthcare Partners LLC Has $34.27 Million Stake in Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Shares Sold by Polar Asset Management Partners Inc. - MarketBeat
ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know - Yahoo Finance
Insulet Corporation $PODD Shares Acquired by Hawk Ridge Capital Management LP - MarketBeat
EFG Asset Management North America Corp. Trims Stock Position in Insulet Corporation $PODD - MarketBeat
Top Executives at Insulet Make Significant Stock Sales! - TipRanks
Canada Pension Plan Investment Board Lowers Position in Insulet Corporation $PODD - MarketBeat
Insulin pump makers Tandem and Insulet post contrasting Q2 results - MSN
Insulet at Baird Global Healthcare: Strategic Growth and Innovation By Investing.com - Investing.com South Africa
Insulet at Baird Global Healthcare: Strategic Growth and Innovation - Investing.com
Transcript : Insulet Corporation Presents at Baird Global Healthcare Conference 2025, Sep-09-2025 12 - MarketScreener
Insulet stock hits all-time high at 350.92 USD - Investing.com
Insulet Stock: Analyst Estimates & Ratings - MSN
인슐렛 코퍼레이션 (PODD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.01%
0.29%
자본화:
|
볼륨(24시간):